Skip to NavigationSkip to content

News

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with COVID-19 under the brand...
Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company has just revealed promising...
An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from...
England’s test and trace programme broke General Data Protection Regulation (GDPR) data law according to the Open Rights Group (ORG).
The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.
AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of hospitalisation risk...
The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential vaccinations...
The FDA has granted a fast Priority Review for Bayer and MSD’s heart failure drug vericiguat.
The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients.
The news this week as usual centres on treatments and vaccines for COVID-19, with Russia claiming it's the first country to complete a vaccine trial...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches